PURE Bioscience, Inc. (PURE)

OTCMKTS: PURE · Delayed Price · USD
0.0700
+0.0030 (4.48%)
Apr 17, 2024, 9:33 AM EDT - Market open
Market Cap 7.83M
Revenue (ttm) 2.06M
Net Income (ttm) -3.65M
Shares Out 111.86M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 36,263
Open 0.0670
Previous Close 0.0670
Day's Range 0.0670 - 0.0700
52-Week Range 0.0600 - 0.1700
Beta 0.07
Analysts n/a
Price Target n/a
Earnings Date Jun 14, 2023

About PURE

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control,... [Read more]

IPO Date Aug 8, 1996
Employees 11
Stock Exchange OTCMKTS
Ticker Symbol PURE
Full Company Profile

Financial Performance

In 2023, PURE's revenue was $1.88 million, an increase of 1.30% compared to the previous year's $1.85 million. Losses were -$3.96 million, 13.3% more than in 2022.

Financial Statements

News

PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results

EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...

4 weeks ago - Business Wire

PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results

EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...

4 months ago - Business Wire

PURE Bioscience Reports Fiscal 2023 Financial Results

EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...

6 months ago - Business Wire

PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, is set to unveil its “PURE Genius” food...

10 months ago - Business Wire

PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...

11 months ago - Business Wire

PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...

1 year ago - Business Wire

PURE Bioscience Reports Fiscal First Quarter 2023 Financial Results

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today...

1 year ago - Business Wire

Hydrite Named Exclusive Distributor for PURE Bioscience in Dairy and Plant-Based Protein Market

BROOKFIELD, Wis. , Nov. 2, 2022 /PRNewswire/ -- Hydrite has entered into a multi-year agreement with PURE Bioscience, Inc. (OTCQB: PURE) to be the exclusive distributor of PURE® Hard Surface disinfect...

1 year ago - PRNewsWire

PURE Bioscience Reports Fiscal 2022 Financial Results

RANCHO CUCAMONGA, Calif.

1 year ago - Business Wire

PURE Bioscience Reports Fiscal 2022 Third Quarter and Nine-Month Financial Results

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...

2 years ago - Business Wire

PURE Bioscience Reports Fiscal 2022 Second Quarter And Six-Month Financial Results

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...

2 years ago - Business Wire

PURE Bioscience Reports Fiscal First Quarter 2022 Financial Results

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today r...

2 years ago - Business Wire

PURE Bioscience Reports Fiscal 2021 Third Quarter and Nine-Month Financial Results

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today r...

3 years ago - Business Wire

PURE Bioscience Reports Fiscal 2021 Second Quarter And Six-Month Financial Results

RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...

3 years ago - Business Wire